October 26, 2022
  • The House Oversight and Reform Committee released a report indicating that some of the nation’s largest insurers and PBMs violate the Affordable Care Act (ACA) by imposing restrictions on birth control products. The investigation found that most companies excluded 34 different contraceptive products and that insurers and PBMs excluded or imposed cost-sharing requirements on about half of contraceptive products approved by the Food and Drug Administration (FDA). The report recommended that the administration issue guidance clarifying that all FDA-approved contraceptive products that do not have a generic equivalent should be covered without cost-sharing as part of every plan or formulary. (Article here)